Published in Can Med Assoc J on May 17, 1975
Letter: Fatal mucocutaneous lymph node syndrome--in Canada? Can Med Assoc J (1976) 0.92
Kawasaki disease, or mucocutaneous lymph node syndrome: report of seven cases in North America. Can Med Assoc J (1980) 0.89
Amputating gangrene in Kawasaki disease. Can Med Assoc J (1982) 0.76
Surgical management of the cardiovascular complications of Kawasaki's disease. Tex Heart Inst J (1983) 0.75
The whiplash syndrome--common sense revisited. J Rheumatol (1997) 7.20
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
The use of standardized patients in the performance of a needs assessment and development of a CME intervention in rheumatology for primary care physicians. J Rheumatol (1997) 2.67
Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study. J Rheumatol (1999) 2.45
Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med (2001) 2.36
Serum transaminases during salicylate therapy. Br Med J (1971) 2.34
The genetics of psoriasis. Haplotype sharing in siblings with the disease. Arch Dermatol (1990) 2.12
Septic arthritis. Ann Rheum Dis (1972) 2.06
Development of persistent neurologic symptoms in patients with simple neck sprain. Arthritis Care Res (1999) 2.05
Alternative therapies--medicine, magic, or quackery. Who is winning the battle? J Rheumatol (1997) 2.00
Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol (2001) 1.93
Use of lumbar radiographs for the early diagnosis of low back pain. Proposed guidelines would increase utilization. JAMA (1997) 1.92
Cell-mediated immunity to herpes simplex virus in man. J Infect Dis (1974) 1.91
Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making (2001) 1.75
Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol (1992) 1.69
An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J Rheumatol (1995) 1.62
Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol (1996) 1.60
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis. Ann Rheum Dis (1978) 1.45
Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun (1975) 1.43
Performance of online biomedical databases in rheumatology. J Rheumatol (1994) 1.42
The art versus the science of medicine. Are clinical practice guidelines the answer? Ann Rheum Dis (1998) 1.40
Combination drug therapy in rheumatoid arthritis. J Rheumatol (1997) 1.40
Generic health instruments do not comprehensively capture patient perceived improvement in patients with carpal tunnel syndrome. J Rheumatol (1999) 1.39
HLA-B27 and arthritis: back to the future. Part I. J Rheumatol (1991) 1.39
The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine. Clin Exp Rheumatol (1989) 1.38
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol (1999) 1.36
Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis (1977) 1.32
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. CMAJ (1996) 1.28
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol (1993) 1.26
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003). Ann Rheum Dis (2003) 1.25
Symptom expectation after minor head injury. A comparative study between Canada and Lithuania. Clin Neurol Neurosurg (2001) 1.21
Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol (1988) 1.20
Scintigraphic findings in ankylosing spondylitis. J Nucl Med (1977) 1.16
Scintigraphy of sacroiliac joints in acute anterior uveitis. A study of thirty patients. Ann Intern Med (1976) 1.16
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
Investigation of sacroiliac disease: Comparative evaluation of radiological and radionuclide techniques. J Rheumatol (1975) 1.13
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
The scintigraphic investigation of sacroiliac disease. J Nucl Med (1977) 1.12
Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int (2006) 1.12
Cell-mediated immunity to herpes simplex virus in man. Am J Clin Pathol (1973) 1.10
Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci (1988) 1.10
Management of rheumatoid arthritis: the historical context. J Rheumatol (2001) 1.09
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol (1989) 1.09
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Neck injury and chronic pain syndromes: comment on the article by Buskila et al. Arthritis Rheum (1998) 1.08
A re-examination of the whiplash associated disorders (WAD) as a systemic illness. Ann Rheum Dis (2005) 1.08
Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol (1977) 1.07
Effects of nitroglycerin on left ventricular volumes and wall tension in patients with ischaemic heart disease. Br Heart J (1970) 1.07
HL-A (transplantation) antigens in ankylosing spondylitis and Crohn's disease. J Rheumatol (1974) 1.06
Antimalarials in rheumatology: efficacy and safety. Semin Arthritis Rheum (1987) 1.06
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol (2001) 1.05
Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol (2001) 1.05
The best approach to the problem of whiplash? One ticket to Lithuania, please. Clin Exp Rheumatol (1999) 1.03
Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis (1975) 1.03
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol (1984) 1.02
Long-term effectiveness of antimalarial drugs in rheumatic diseases. Ann Rheum Dis (1998) 1.01
Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness. J Rheumatol (1995) 1.01
A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man. Immunology (1978) 1.01
Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol (1984) 1.00
Epidemiology of whiplash: an international dilemma. Ann Rheum Dis (1999) 0.99
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98
Analysis of DNA structure by hydroxyapatite columns and ethidium bromide fluorescence techniques. A comparative study and effect on DNA binding. Arthritis Rheum (1978) 0.98
An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol (1998) 0.97
Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor. J Rheumatol (1996) 0.97
An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference. Can J Clin Pharmacol (2000) 0.97
Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. J Rheumatol (1999) 0.96
Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J Pharm Sci (1988) 0.96
Ibuprofen: a severe systemic reaction. Can Med Assoc J (1983) 0.96
The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity. J Rheumatol (1982) 0.96
Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol (1994) 0.96
Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol (1995) 0.96
Adverse reaction to sulfasalazine. J Rheumatol (1988) 0.95
The sacroiliitis of acute Reiter's syndrome. J Rheumatol (1977) 0.95
Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int (2010) 0.94
Sacroiliitis detected by bone scintiscanning: a clinical, radiological, and scintigraphic follow-up study. Ann Rheum Dis (1979) 0.94
HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis? Semin Arthritis Rheum (1994) 0.93
Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease. Cancer (1977) 0.93
Arginase production by peritoneal macrophages: a new assay. J Immunol Methods (1980) 0.93
Fibroblast lysis by lymphocytes from normal persons and SLE patients on short-term cultures. Immunology (1976) 0.93
Immunofluorescent technique for the detection of antibodies to n-DNA: comparison with radioimmunoassay. J Rheumatol (1977) 0.92
Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. J Rheumatol Suppl (1982) 0.92
Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Clin Exp Rheumatol (1994) 0.92
A comparative study of technics for the detection of antibodies to native deoxyribonucleic acid. Am J Clin Pathol (1977) 0.92
Ankylosing spondylitis and multiple sclerosis: an apparent association? J Rheumatol (1988) 0.92
Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. J Pharm Sci (1988) 0.92
Combining NSAIDs with anticoagulants: yes and no. Can Med Assoc J (1984) 0.92
Variations and trends in the prescription of initial second line therapy for patients with rheumatoid arthritis. J Rheumatol (1997) 0.92
Malfunction of the mitral valve prosthesis (Cutter-Smeloff). Clinical and hemodynamic observations in three cases. Circulation (1970) 0.91
The antigenicity of polynucleotides in mink, rabbit, and man. J Rheumatol (1974) 0.91
Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol (1997) 0.91
Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. J Pharm Sci (1992) 0.90
Computer assisted tomography of the apophyseal changes in patients with ankylosing spondylitis. J Rheumatol (1986) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Spleen cell cytotoxicity in New Zealand black mice (NZB) with autoimmune disease. J Immunol (1973) 0.89